Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1039/D3RA04874H | ||||
| Año | 2023 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
In this study, two pyrazolo[3,4-b]pyridine derivatives (4a and 4b) were grown using a slow evaporation solution growth technique and characterized by FT-IR, HRMS, 1H/13C NMR spectroscopy, and X-ray crystallography. The 4a and 4b structures crystallized in monoclinic and triclinic systems with space groups P21/n and P1̄, respectively. Theoretical calculations were performed at the DFT/B3LYP level for the optimized geometries. The results were in excellent agreement with the experimental data (spectroscopic and XRD). This investigation encompasses molecular modeling studies including Hirshfeld surface analysis, energy framework calculations, and frontier molecular orbital analysis. Intermolecular interactions within the crystal structures of the compounds were explored through Hirshfeld surface analysis, which revealed the notable presence of hydrogen bonding and hydrophobic interactions. This insight provides valuable information on the structural stability and potential solubility characteristics of these compounds. The research was extended to docking analysis with eight distinct kinases (BRAF, HER2, CSF1R, MEK2, PDGFRA, JAK, AKT1, and AKT2). The results of this analysis demonstrate that both 4a and 4b interact effectively with the kinase-binding sites through a combination of hydrophobic interactions and hydrogen bonding. Compound 4a had the best affinity for proteins; this is related to the fact that the compound is not rigid and has a small size, allowing it to sit well at any binding site. This study contributes to the advancement of kinase inhibitor research and offers potential avenues for the development of new therapeutic agents for cancer treatment.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Polo, Efrain | Hombre |
Universidad de Talca - Chile
|
| 2 | López-Cuellar, Lorena | - |
Universidad de Talca - Chile
Universidad de la Amazonia - Colombia Univ Amazonia - Colombia |
| 3 | Acosta-Quiroga, Karen | Mujer |
Universidad de Chile - Chile
|
| 4 | Rojas-Pena, Cristian | Hombre |
Universidad de Chile - Chile
|
| 5 | BRITO-BOBADILLA, IVAN LEANDRO | Hombre |
Universidad de Antofagasta - Chile
|
| 6 | Cisterna, Jonathan | Hombre |
Universidad Católica del Norte - Chile
|
| 7 | Trilleras, Jorge | Hombre |
Universidad del Atlántico, Colombia - Colombia
Univ Atlantico - Colombia |
| 8 | ALDERETE-TRIVINOS, JOEL BERNABE | Hombre |
Universidad de Talca - Chile
|
| 9 | Duarte, Y. | - |
Universidad Nacional Andrés Bello - Chile
Universidad de Valparaíso - Chile Universidad - Chile Facultad de Ciencias de la Vida - Chile |
| 10 | GUTIERREZ-GARCIA, MARIA GLORIA | Mujer |
Universidad de Talca - Chile
|
| Fuente |
|---|
| FONDEQUIP |
| Fondequip Program |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Universidad de Talca |
| Fondecyt Project |
| FONDECYT post-doctoral fellowship |
| Research Group of the Laboratory of Organic Synthesis and Biological Activity of the University of Talca |
| The authors acknowledge the Research Group of the Laboratory of Organic Synthesis and Biological Activity of the University of Talca. E. P.-C. Thanks FONDECYT Post-Doctoral Fellowship No. 3220681. Fondecyt Project 1200531 the authors also acknowledge FONDE |
| Agradecimiento |
|---|
| The authors acknowledge the Research Group of the Laboratory of Organic Synthesis and Biological Activity of the University of Talca. E. P.-C. Thanks FONDECYT Post-Doctoral Fellowship No. 3220681. Fondecyt Project 1200531 the authors also acknowledge FONDEQUIP program (EQM 130021, 160063 and 180024). |
| The authors acknowledge the Research Group of the Laboratory of Organic Synthesis and Biological Activity of the University of Talca. E. P.-C. Thanks FONDECYT Post-Doctoral Fellowship No. 3220681. Fondecyt Project 1200531 the authors also acknowledge FONDEQUIP program (EQM 130021, 160063 and 180024). |